<DOC>
	<DOCNO>NCT02909907</DOCNO>
	<brief_summary>To compare efficacy botulinum toxin ( BoNT ) injection forearm flexor plus extensor muscle versus flexor alone treatment essential hand tremor ( ET ) .</brief_summary>
	<brief_title>Comparison Botulinum Toxin Injections Forearm FLexor Plus EXtensor Muscles Versus Flexor Muscles Alone Treatment Essential Hand Tremor ( FLEX-D ET )</brief_title>
	<detailed_description>The investigator propose pilot , single center , double blind , randomize , parallel , placebo control trial compare 2 ( BoNT ) injection pattern treatment moderate severe essential tremor . The investigator recruit 20 patient ( ET ) .</detailed_description>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>1 . Age 18 , male female patient ( ET ) involve least dominant hand , diagnose movement disorder neurologist . 2 . Having bothersome hand tremor dominant hand hand TRS ≥2 3 . On stable medication last 30 day prior enrollment . 1 . Presence secondary cause tremor , dystonia parkinsonism 2 . Any contraindication botulinum toxin injection ( e.g . motor neuron disease , neuromuscular junction disease , etc . ) 3 . History surgical treatment ( ET ) . 4 . Dementia define DSMV criterion 5 . Patients suboptimally treat depression significant depressive symptom define PHQ9 score ≥15 ( PHQ9 score 14 Minimal depression ; 59 Mild depression ; 1014 Moderate depression ; 1519 Moderately severe depression ; 2027 Severe depression ) . Antidepressant medication , prescribe depression anxiety , allow patient stable dose least 30 day . 6 . Patients suboptimally treat anxiety significant anxiety symptom define GAD7 score ≥15 ( GAD7 score 04 : minimal anxiety ; 59 : mild anxiety ; 1014 : moderate anxiety ; 1521 : severe anxiety ) . Antianxiety medication , prescribe anxiety , allow patient stable dose least 30 day . 7 . Significant renal , hepatic , cardiac thyroid disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>